Vistagen Therapeutics director Paul Edick resigns; board vacancy to be filled

Vistagen Therapeutics, Inc.

Paul Edick resigned from the Board of Directors effective February 13, 2026.
The Company is actively seeking new candidates to fill the resulting vacancy.
No reason for resignation was disclosed in the filing.

item 5.02

Vistagen Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-010035

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.